Practical Application of Coronary Physiologic Assessment: Asia-Pacific Expert Consensus Document: Part 2.

Coronary physiologic assessment is performed to measure coronary pressure, flow, and resistance or their surrogates to enable the selection of appropriate management strategy and its optimization for patients with coronary artery disease. The value of physiologic assessment is supported by a large body of clinical data that has led to major recommendations in all practice guidelines. This expert consensus document aims to convey practical and balanced recommendations and future perspectives for coronary physiologic assessment for physicians and patients in the Asia-Pacific region, based on updated information in the field that includes both wire- and image-based physiologic assessment. This is Part 2 of the whole consensus document, which provides theoretical and practical information on physiologic indexes for specific clinical conditions and patient statuses.

Informations de copyright

© 2023 The Authors.

Déclaration de conflit d'intérêts

This work is supported by the grant from the Patient-Centered Clinical Research Coordinating Center (grant number HC19C0305). Dr Koo has received Institutional Research Grants from Abbott Vascular, Boston Scientific, Philips, and HeartFlow. Dr Wang has received institutional research grants from Boston Scientific. Dr Harding has received proctoring fees and speaker honoraria from Abbott Vascular, Boston Scientific, Medtronic, and Terumo Medical. Dr Fearon has received institutional research support from Abbott, Boston Scientific, and Medtronic; has consulting relationships with CathWorks and Siemens; and has stock options with HeartFlow. Dr Lee has received institutional research grants from Abbott Vascular, Boston Scientific, Philips Volcano, Terumo Corporation, Zoll Medical, and Donga-ST. Dr Hu has received institutional research grants from Boston Scientific. Dr Yong has received minor honoraria from Abbott Vascular and institutional research grants and support from Abbott Vascular and Philips. Dr Kuramitsu has received lecture fees from Abbott Medical Japan and Boston Scientific Japan. Dr Jeong has received honoraria for lectures from Daiichi Sankyo, Sanofi-Aventis, Han-mi Pharmaceuticals, and JW Pharmaceuticals and research grants or support from Han-mi Pharmaceuticals, Samjin Pharmaceuticals, Yuhan Pharmaceuticals, Biotronik, Dio Medical, and U and I Corporation. Dr Escaned has received personal fees as speaker or advisory board member from Abbott, Boston Scientific, Medis, RainMed, and Philips; he has reported joint ownership of angio-IMR patent. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.